0001628280-26-029528
SEC filingPrenetics Global Limited authorized divestment of its entire 510 Bitcoin treasury holdings for expected gross proceeds of approximately $40 million to support IM8 business growth and share repurchases.
Prenetics Global Limited's decision to fully divest its Bitcoin treasury of approximately 510 BTC marks a strategic pivot away from cryptocurrency holdings toward its core IM8 consumer health business. The Board views capital deployment in IM8 as higher-conviction, given the brand's scale and targeted FY2026 revenue of $180-200 million. The sale, set for completion by May 14, 2026, via institutional OTC desks, is expected to yield ~$40 million gross proceeds at recent $80,000/BTC prices, though subject to market fluctuations and fees. This will boost liquidity from the March 31, 2026 position of $112 million (cash equivalents $56M, financial assets $50M, escrow $6M) to $145-150 million post-sale and ordinary operations, with zero indebtedness. Proceeds allocation prioritizes expanding the existing $40 million share repurchase program—signaling strong equity valuation confidence—alongside accelerating IM8 DTC marketing with proven unit economics, Q4 2026 SKU launches, and penetration into 40+ countries. The no-future-crypto policy underscores focus on operational growth. Final proceeds and VWAP sale price will be disclosed with Q1 FY2026 results on May 14, 2026, with gains/losses in Q2 statements.